Mining the genome for lipid genes

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 10, 2014, Pages 1993-2009

  Kuivenhoven, Jan Albert ^a   Hegele, Robert A ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Gene discovery; Lipoprotein; Primary dyslipidemia; Secondary dyslipidemia

Indexed keywords

ADAPTOR PROTEIN; ANGPLT3 PROTEIN; APOLIPOPROTEIN A5; LIPID; LIPOPROTEIN; PCSK9 PROTEIN; UNCLASSIFIED DRUG;

BIOINFORMATICS; DYSLIPIDEMIA; EXOME; GENE PRODUCT; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; HUMAN; IN VITRO STUDY; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MOLECULAR GENETICS; NONHUMAN; PHENOTYPE; REVIEW; WILD TYPE;

EID: 84908329714     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.04.028     Document Type: Review

References (218)

1. Abifadel M., Varret M., Rabes J.P., Allard D., Ouguerram K., Devillers M., Cruaud C., Benjannet S., Wickham L., Erlich D., Derre A., Villeger L., Farnier M., Beucler I., Bruckert E., Chambaz J., Chanu B., Lecerf J.M., Luc G., Moulin P., Weissenbach J., Prat A., Krempf M., Junien C., Seidah N.G., Boileau C. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat. Genet. 2003, 34:154-156.
2. Abifadel M., Rabes J.P., Devillers M., Munnich A., Erlich D., Junien C., Varret M., Boileau C. Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease. Hum Mutat. Apr. 2009, 30(4):520-529. Review. PMID: 19191301. 10.1002/humu.20882.
3. Acton S.L., Scherer P.E., Lodish H.F., Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 1994, 269:21003-21009.
4. Agarwal A.K., Arioglu E., De A.S., Akkoc N., Taylor S.I., Bowcock A.M., Barnes R.I., Garg A. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat. Genet. 2002, 31:21-23.
5. Agarwal A.K., Fryns J.P., Auchus R.J., Garg A. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum. Mol. Genet. 2003, 12:1995-2001.
6. Agellon L.B., Walsh A., Hayek T., Moulin P., Jiang X.C., Shelanski S.A., Breslow J.L., Tall A.R. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J. Biol. Chem. 1991, 266:10796-10801.
7. Aguilar-Salinas C.A., Reyes-Rodriguez E., Ordonez-Sanchez M.L., Torres M.A., Ramirez-Jimenez S., Dominguez-Lopez A., Martinez-Francois J.R., Velasco-Perez M.L., Alpizar M., Garcia-Garcia E., Gomez-Perez F., Rull J., Tusie-Luna M.T. Early-onset type 2 diabetes: metabolic and genetic characterization in the Mexican population. J. Clin. Endocrinol. Metab. 2001, 86:220-226.
8. Allan C.M., Taylor J.M. Expression of a novel human apolipoprotein (apoC-IV) causes hypertriglyceridemia in transgenic mice. J. Lipid Res. 1996, 37:1510-1518.
9. Alvarado C.S., Straus S.E., Li S., Dale J.K., Mann K., Le A., Lauer S.J. Autoimmune lymphoproliferative syndrome: a cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children-report on diagnosis and management of five patients. Pediatr. Blood Cancer 2004, 43:164-169.
10. Attie A.D., Hamon Y., Brooks-Wilson A.R., Gray-Keller M.P., MacDonald M.L., Rigot V., Tebon A., Zhang L.H., Mulligan J.D., Singaraja R.R., Bitgood J.J., Cook M.E., Kastelein J.J., Chimini G., Hayden M.R. Identification and functional analysis of a naturally occurring E89K mutation in the ABCA1 gene of the WHAM chicken. J. Lipid Res. 2002, 43:1610-1617.
11. Aubert R., Herzog J., Camus M.C., Guenet J.L., Lemonnier D. Description of a new model of genetic obesity: the dbPas mouse. J. Nutr. 1985, 115:327-333.
12. Awan Z., Choi H.Y., Stitziel N., Ruel I., Bamimore M.A., Husa R., Gagnon M.H., Wang R.H., Peloso G.M., Hegele R.A., Seidah N.G., Kathiresan S., Genest J. APOE p.Leu167del mutation in familial hypercholesterolemia. Atherosclerosis 2013, 231:218-222.
13. Basel-Vanagaite L., Zevit N., Har Z.A., Guo L., Parathath S., Pasmanik-Chor M., McIntyre A.D., Wang J., Albin-Kaplanski A., Hartman C., Marom D., Zeharia A., Badir A., Shoerman O., Simon A.J., Rechavi G., Shohat M., Hegele R.A., Fisher E.A., Shamir R. Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1. Am. J. Hum. Genet. 2012, 90:49-60.
14. Basford J.E., Wancata L., Hofmann S.M., Silva R.A., Davidson W.S., Howles P.N., Hui D.Y. Hepatic deficiency of low density lipoprotein receptor-related protein-1 reduces high density lipoprotein secretion and plasma levels in mice. J. Biol. Chem. 2011, 286:13079-13087.
15. Beigneux A.P., Franssen R., Bensadoun A., Gin P., Melford K., Peter J., Walzem R.L., Weinstein M.M., Davies B.S., Kuivenhoven J.A., Kastelein J.J., Fong L.G., Dallinga-Thie G.M., Young S.G. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase. Arterioscler. Thromb. Vasc. Biol. 2009, 29:956-962.
16. Berge K.E., Tian H., Graf G.A., Yu L., Grishin N.V., Schultz J., Kwiterovich P., Shan B., Barnes R., Hobbs H.H. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 2000, 290:1771-1775.
17. Bernstein D.L., Hulkova H., Bialer M.G., Desnick R.J. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J. Hepatol. 2013, 58:1230-1243.
18. Birjmohun R.S., Dallinga-Thie G.M., Kuivenhoven J.A., Stroes E.S., Otvos J.D., Wareham N.J., Luben R., Kastelein J.J., Khaw K.T., Boekholdt S.M. Apolipoprotein A-II is inversely associated with risk of future coronary artery disease. Circulation 2007, 116:2029-2035.
19. Bodnar J.S., Chatterjee A., Castellani L.W., Ross D.A., Ohmen J., Cavalcoli J., Wu C., Dains K.M., Catanese J., Chu M., Sheth S.S., Charugundla K., Demant P., West D.B., de Jong P., Lusis A.J. Positional cloning of the combined hyperlipidemia gene Hyplip1. Nat. Genet. 2002, 30:110-116.
20. Bodzioch M., Orso E., Klucken J., Langmann T., Bottcher A., Diederich W., Drobnik W., Barlage S., Buchler C., Porsch-Ozcurumez M., Kaminski W.E., Hahmann H.W., Oette K., Rothe G., Aslanidis C., Lackner K.J., Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 1999, 22:347-351.
21. Boycott K.M., Vanstone M.R., Bulman D.E., MacKenzie A.E. Rare-disease genetics in the era of next-generation sequencing: discovery to translation. Nat. Rev. Genet. 2013, 14:681-691.
22. Brooks-Wilson A., Marcil M., Clee S.M., Zhang L.H., Roomp K., van Dam M., Yu L., Brewer C., Collins J.A., Molhuizen H.O., Loubser O., Ouelette B.F., Fichter K., Ashbourne-Excoffon K.J., Sensen C.W., Scherer S., Mott S., Denis M., Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J.J., Genest J., Hayden M.R. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 1999, 22:336-345.
23. Brown L.J., Koza R.A., Everett C., Reitman M.L., Marshall L., Fahien L.A., Kozak L.P., MacDonald M.J. Normal thyroid thermogenesis but reduced viability and adiposity in mice lacking the mitochondrial glycerol phosphate dehydrogenase. J. Biol. Chem. 2002, 277:32892-32898.
24. Brown L.J., Koza R.A., Marshall L., Kozak L.P., MacDonald M.J. Lethal hypoglycemic ketosis and glyceroluria in mice lacking both the mitochondrial and the cytosolic glycerol phosphate dehydrogenases. J. Biol. Chem. 2002, 277:32899-32904.
25. Brown M.L., Inazu A., Hesler C.B., Agellon L.B., Mann C., Whitlock M.E., Marcel Y.L., Milne R.W., Koizumi J., Mabuchi H. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 1989, 342:448-451.
26. Buchmann J., Meyer C., Neschen S., Augustin R., Schmolz K., Kluge R., Al-Hasani H., Jurgens H., Eulenberg K., Wehr R., Dohrmann C., Joost H.G., Schurmann A. Ablation of the cholesterol transporter adenosine triphosphate-binding cassette transporter G1 reduces adipose cell size and protects against diet-induced obesity. Endocrinology 2007, 148:1561-1573.
27. Burkhardt R., Toh S.A., Lagor W.R., Birkeland A., Levin M., Li X., Robblee M., Fedorov V.D., Yamamoto M., Satoh T., Akira S., Kathiresan S., Breslow J.L., Rader D.J. Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice. J. Clin. Invest. 2010, 120:4410-4414.
28. Busch S.J., Barnhart R.L., Martin G.A., Fitzgerald M.C., Yates M.T., Mao S.J., Thomas C.E., Jackson R.L. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J. Biol. Chem. 1994, 269:16376-16382.
29. Callow M.J., Verstuyft J., Tangirala R., Palinski W., Rubin E.M. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a). J. Clin. Invest. 1995, 96:1639-1646.
30. Cao H., Hegele R.A. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 2000, 9:109-112.
31. Chambers J.C., Zhang W., Sehmi J., Li X., Wass M.N., Van der Harst P., Holm H., Sanna S., Kavousi M., Baumeister S.E., Coin L.J., Deng G., Gieger C., Heard-Costa N.L., Hottenga J.J., Kuhnel B., Kumar V., Lagou V., Liang L., Luan J., Vidal P.M., Mateo Leach I., O'Reilly P.F., Peden J.F., Rahmioglu N., Soininen P., Speliotes E.K., Yuan X., Thorleifsson G., Alizadeh B.Z., Atwood L.D., Borecki I.B., Brown M.J., Charoen P., Cucca F., Das D., de Geus E.J., Dixon A.L., Doring A., Ehret G., Eyjolfsson G.I., Farrall M., Forouhi N.G., Friedrich N., Goessling W., Gudbjartsson D.F., Harris T.B., Hartikainen A.L., Heath S., Hirschfield G.M., Hofman A., Homuth G., Hypponen E., Janssen H.L., Johnson T., Kangas A.J., Kema I.P., Kuhn J.P., Lai S., Lathrop M., Lerch M.M., Li Y., Liang T.J., Lin J.P., Loos R.J., Martin N.G., Moffatt M.F., Montgomery G.W., Munroe P.B., Musunuru K., Nakamura Y., O'Donnell C.J., Olafsson I., Penninx B.W., Pouta A., Prins B.P., Prokopenko I., Puls R., Ruokonen A., Savolainen M.J., Schlessinger D., Schouten J.N., Seedorf U., Sen-Chowdhry S., Siminovitch K.A., Smit J.H., Spector T.D., Tan W., Teslovich T.M., Tukiainen T., Uitterlinden A.G., Van der Klauw M.M., Vasan R.S., Wallace C., Wallaschofski H., Wichmann H.E., Willemsen G., Wurtz P., Xu C., Yerges-Armstrong L.M., Abecasis G.R., Ahmadi K.R., Boomsma D.I., Caulfield M., Cookson W.O., van Duijn C.M., Froguel P., Matsuda K., McCarthy M.I., Meisinger C., Mooser V., Pietilainen K.H., Schumann G., Snieder H., Sternberg M.J., Stolk R.P., Thomas H.C., Thorsteinsdottir U., Uda M., Waeber G., Wareham N.J., Waterworth D.M., Watkins H., Whitfield J.B., Witteman J.C., Wolffenbuttel B.H., Fox C.S., Ala-Korpela M., Stefansson K., Vollenweider P., Volzke H., Schadt E.E., Scott J., Jarvelin M.R., Elliott P., Kooner J.S. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat. Genet. 2011, 43:1131-1138.
32. Chan D.C., Ng T.W., Watts G.F. Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis. Ann. Med. 2012, 44:313-324.
33. Chen W.S., Manova K., Weinstein D.C., Duncan S.A., Plump A.S., Prezioso V.R., Bachvarova R.F., Darnell J.E. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev. 1994, 8:2466-2477.
34. Christophersen B., Nordstoga K., Shen Y., Olivecrona T., Olivecrona G. Lipoprotein lipase deficiency with pancreatitis in mink: biochemical characterization and pathology. J. Lipid Res. 1997, 38:837-846.
35. Chroni A., Kan H.Y., Kypreos K.E., Gorshkova I.N., Shkodrani A., Zannis V.I. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice. Biochemistry 2004, 43:10442-10457.
36. Chroni A., Kan H.Y., Shkodrani A., Liu T., Zannis V.I. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice. Biochemistry 2005, 44:4108-4117.
37. Churchill G.A., Airey D.C., Allayee H., Angel J.M., Attie A.D., Beatty J., Beavis W.D., Belknap J.K., Bennett B., Berrettini W., Bleich A., Bogue M., Broman K.W., Buck K.J., Buckler E., Burmeister M., Chesler E.J., Cheverud J.M., Clapcote S., Cook M.N., Cox R.D., Crabbe J.C., Crusio W.E., Darvasi A., Deschepper C.F., Doerge R.W., Farber C.R., Forejt J., Gaile D., Garlow S.J., Geiger H., Gershenfeld H., Gordon T., Gu J., Gu W., de Haan G., Hayes N.L., Heller C., Himmelbauer H., Hitzemann R., Hunter K., Hsu H.C., Iraqi F.A., Ivandic B., Jacob H.J., Jansen R.C., Jepsen K.J., Johnson D.K., Johnson T.E., Kempermann G., Kendziorski C., Kotb M., Kooy R.F., Llamas B., Lammert F., Lassalle J.M., Lowenstein P.R., Lu L., Lusis A., Manly K.F., Marcucio R., Matthews D., Medrano J.F., Miller D.R., Mittleman G., Mock B.A., Mogil J.S., Montagutelli X., Morahan G., Morris D.G., Mott R., Nadeau J.H., Nagase H., Nowakowski R.S., O'Hara B.F., Osadchuk A.V., Page G.P., Paigen B., Paigen K., Palmer A.A., Pan H.J., Peltonen-Palotie L., Peirce J., Pomp D., Pravenec M., Prows D.R., Qi Z., Reeves R.H., Roder J., Rosen G.D., Schadt E.E., Schalkwyk L.C., Seltzer Z., Shimomura K., Shou S., Sillanpaa M.J., Siracusa L.D., Snoeck H.W., Spearow J.L., Svenson K., Tarantino L.M., Threadgill D., Toth L.A., Valdar W., de Villena F.P., Warden C., Whatley S., Williams R.W., Wiltshire T., Yi N., Zhang D., Zhang M., Zou F. The Collaborative Cross, a community resource for the genetic analysis of complex traits. Nat. Genet. 2004, 36:1133-1137.
38. Cladaras C., Hadzopoulou-Cladaras M., Felber B.K., Pavlakis G., Zannis V.I. The molecular basis of a familial apoE deficiency. An acceptor splice site mutation in the third intron of the deficient apoE gene. J. Biol. Chem. 1987, 262:2310-2315.
39. Cohen J., Pertsemlidis A., Kotowski I.K., Graham R., Garcia C.K., Hobbs H.H. Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. Nat. Genet. 2005, 37:161-165.
40. Cox D.W., Breckenridge W.C., Little J.A. Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis. N. Engl. J. Med. 1978, 299:1421-1424.
41. Deeb S.S., Takata K., Peng R.L., Kajiyama G., Albers J.J. A splice-junction mutation responsible for familial apolipoprotein A-II deficiency. Am. J. Hum. Genet. 1990, 46:822-827.
42. Di A.E., Sarwar N., Perry P., Kaptoge S., Ray K.K., Thompson A., Wood A.M., Lewington S., Sattar N., Packard C.J., Collins R., Thompson S.G., Danesh J. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009, 302:1993-2000.
43. Dollet L., Magre J., Cariou B., Prieur X. Function of seipin: new insights from Bscl2/seipin knockout mouse models. Biochimie 2014, 96:166-172.
44. Dornas W.C., Oliveira T.T., Augusto L.E., Nagem T.J. Experimental atherosclerosis in rabbits. Arq. Bras. Cardiol. 2010, 95:272-278.
45. Du H., Duanmu M., Witte D., Grabowski G.A. Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage. Hum. Mol. Genet. 1998, 7:1347-1354.
46. Dube J.B., Johansen C.T., Hegele R.A. Sortilin: an unusual suspect in cholesterol metabolism: from GWAS identification to in vivo biochemical analyses, sortilin has been identified as a novel mediator of human lipoprotein metabolism. Bioessays 2011, 33:430-437.
47. Ebara T., Ramakrishnan R., Steiner G., Shachter N.S. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E. J. Clin. Invest. 1997, 99:2672-2681.
48. Eckey R., Menschikowski M., Lattke P., Jaross W. Increased hepatic cholesterol accumulation in transgenic mice overexpressing human secretory phospholipase A2 group IIA. Inflammation 2004, 28:59-65.
49. Ellard S. Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young. Hum. Mutat. 2000, 16:377-385.
50. Emi M., Wilson D.E., Iverius P.H., Wu L., Hata A., Hegele R., Williams R.R., Lalouel J.M. Missense mutation (Gly→Glu188) of human lipoprotein lipase imparting functional deficiency. J. Biol. Chem. 1990, 265:5910-5916.
51. Escary J.L., Choy H.A., Reue K., Wang X.P., Castellani L.W., Glass C.K., Lusis A.J., Schotz M.C. Paradoxical effect on atherosclerosis of hormone-sensitive lipase overexpression in macrophages. J. Lipid Res. 1999, 40:397-404.
52. Figueira T.R., Vercesi A.E., Oliveira H.C. Lack of plasma albumin impairs intravascular lipolysis and explains the associated free fatty acids deficiency and hypertriglyceridemia. Lipids Health Dis. 2010, 9:146.
53. Fischer J., Lefevre C., Morava E., Mussini J.M., Laforet P., Negre-Salvayre A., Lathrop M., Salvayre R. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat. Genet. 2007, 39:28-30.
54. Flowers M.T., Groen A.K., Oler A.T., Keller M.P., Choi Y., Schueler K.L., Richards O.C., Lan H., Miyazaki M., Kuipers F., Kendziorski C.M., Ntambi J.M., Attie A.D. Cholestasis and hypercholesterolemia in SCD1-deficient mice fed a low-fat, high-carbohydrate diet. J. Lipid Res. 2006, 47:2668-2680.
55. Francone O.L., Ishida B.Y., Llera-Moya M., Royer L., Happe C., Zhu J., Chalkey R.J., Schaefer P., Cox C., Burlingame A., Kane J.P., Rothblat G.H. Disruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levels. J. Lipid Res. 2011, 52:1974-1983.
56. Funke H., von Eckardstein A., Pritchard P.H., Albers J.J., Kastelein J.J., Droste C., Assmann G. A molecular defect causing fish eye disease: an amino acid exchange in lecithin-cholesterol acyltransferase (LCAT) leads to the selective loss of alpha-LCAT activity. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:4855-4859.
57. Gandotra S., Le D.C., Bottomley W., Cervera P., Giral P., Reznik Y., Charpentier G., Auclair M., Delepine M., Barroso I., Semple R.K., Lathrop M., Lascols O., Capeau J., O'Rahilly S., Magre J., Savage D.B., Vigouroux C. Perilipin deficiency and autosomal dominant partial lipodystrophy. N. Engl. J. Med. 2011, 364:740-748.
58. Garcia C.K., Wilund K., Arca M., Zuliani G., Fellin R., Maioli M., Calandra S., Bertolini S., Cossu F., Grishin N., Barnes R., Cohen J.C., Hobbs H.H. Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 2001, 292:1394-1398.
59. Goode E.L., Cherny S.S., Christian J.C., Jarvik G.P., de Andrade M. Heritability of longitudinal measures of body mass index and lipid and lipoprotein levels in aging twins. Twin. Res. Hum. Genet. 2007, 10:703-711.
60. Gotoda T., Yamada N., Murase T., Sakuma M., Murayama N., Shimano H., Kozaki K., Albers J.J., Yazaki Y., Akanuma Y. Differential phenotypic expression by three mutant alleles in familial lecithin:cholesterol acyltransferase deficiency. Lancet 1991, 338:778-781.
61. Graul-Neumann L.M., Kienitz T., Robinson P.N., Baasanjav S., Karow B., Gillessen-Kaesbach G., Fahsold R., Schmidt H., Hoffmann K., Passarge E. Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3' terminus of the FBN1-gene. Am. J. Med. Genet. A 2010, 152A:2749-2755.
62. Haemmerle G., Lass A., Zimmermann R., Gorkiewicz G., Meyer C., Rozman J., Heldmaier G., Maier R., Theussl C., Eder S., Kratky D., Wagner E.F., Klingenspor M., Hoefler G., Zechner R. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006, 312:734-737.
63. Hayashi Y.K., Matsuda C., Ogawa M., Goto K., Tominaga K., Mitsuhashi S., Park Y.E., Nonaka I., Hino-Fukuyo N., Haginoya K., Sugano H., Nishino I. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J. Clin. Invest. 2009, 119:2623-2633.
64. Hegele R.A., Cao H., Frankowski C., Mathews S.T., Leff T. PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy. Diabetes 2002, 51:3586-3590.
65. Hegele R.A., Little J.A., Connelly P.W. Compound heterozygosity for mutant hepatic lipase in familial hepatic lipase deficiency. Biochem. Biophys. Res. Commun. 1991, 179:78-84.
66. Hinds D.A., Seymour A.B., Durham L.K., Banerjee P., Ballinger D.G., Milos P.M., Cox D.R., Thompson J.F., Frazer K.A. Application of pooled genotyping to scan candidate regions for association with HDL cholesterol levels. Hum. Genom. 2004, 1:421-434.
67. Hirano K., Matsuura F., Tsukamoto K., Zhang Z., Matsuyama A., Takaishi K., Komuro R., Suehiro T., Yamashita S., Takai Y., Matsuzawa Y. Decreased expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease - the small G protein may play a role in cholesterol efflux. FEBS Lett. 2000, 484:275-279.
68. Holleboom A.G., Karlsson H., Lin R.S., Beres T.M., Sierts J.A., Herman D.S., Stroes E.S., Aerts J.M., Kastelein J.J., Motazacker M.M., Dallinga-Thie G.M., Levels J.H., Zwinderman A.H., Seidman J.G., Seidman C.E., Ljunggren S., Lefeber D.J., Morava E., Wevers R.A., Fritz T.A., Tabak L.A., Lindahl M., Hovingh G.K., Kuivenhoven J.A. Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man. Cell Metab. 2011, 14:811-818.
69. Homanics G.E., de Silva H.V., Osada J., Zhang S.H., Wong H., Borensztajn J., Maeda N. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J. Biol. Chem. 1995, 270:2974-2980.
70. Horinouchi K., Erlich S., Perl D.P., Ferlinz K., Bisgaier C.L., Sandhoff K., Desnick R.J., Stewart C.L., Schuchman E.H. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat. Genet. 1995, 10:288-293.
71. Huang L.S., Voyiaziakis E., Markenson D.F., Sokol K.A., Hayek T., Breslow J.L. apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes. J. Clin. Invest. 1995, 96:2152-2161.
72. Illig T., Gieger C., Zhai G., Romisch-Margl W., Wang-Sattler R., Prehn C., Altmaier E., Kastenmuller G., Kato B.S., Mewes H.W., Meitinger T., de Angelis M.H., Kronenberg F., Soranzo N., Wichmann H.E., Spector T.D., Adamski J., Suhre K. A genome-wide perspective of genetic variation in human metabolism. Nat. Genet. 2010, 42:137-141.
73. Ioka R.X., Kang M.J., Kamiyama S., Kim D.H., Magoori K., Kamataki A., Ito Y., Takei Y.A., Sasaki M., Suzuki T., Sasano H., Takahashi S., Sakai J., Fujino T., Yamamoto T.T. Expression cloning and characterization of a novel glycosylphosphatidylinositol-ted high density lipoprotein-binding protein, GPI-HBP1. J. Biol. Chem. 2003, 278:7344-7349.
74. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 1993, 92:883-893.
75. Ishida T., Choi S., Kundu R.K., Hirata K., Rubin E.M., Cooper A.D., Quertermous T. Endothelial lipase is a major determinant of HDL level. J. Clin. Invest. 2003, 111:347-355.
76. Isoda K., Sawada S., Ayaori M., Matsuki T., Horai R., Kagata Y., Miyazaki K., Kusuhara M., Okazaki M., Matsubara O., Iwakura Y., Ohsuzu F. Deficiency of interleukin-1 receptor antagonist deteriorates fatty liver and cholesterol metabolism in hypercholesterolemic mice. J. Biol. Chem. 2005, 280:7002-7009.
77. Jacobs R.L., Devlin C., Tabas I., Vance D.E. Targeted deletion of hepatic CTP:phosphocholine cytidylyltransferase alpha in mice decreases plasma high density and very low density lipoproteins. J. Biol. Chem. 2004, 279:47402-47410.
78. Jaye M., Lynch K.J., Krawiec J., Marchadier D., Maugeais C., Doan K., South V., Amin D., Perrone M., Rader D.J. A novel endothelial-derived lipase that modulates HDL metabolism. Nat. Genet. 1999, 21:424-428.
79. Jiang X.C., Bruce C., Mar J., Lin M., Ji Y., Francone O.L., Tall A.R. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J. Clin. Invest. 1999, 103:907-914.
80. Jiang X.C., Masucci-Magoulas L., Mar J., Lin M., Walsh A., Breslow J.L., Tall A. Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles. J. Biol. Chem. 1993, 268:27406-27412.
81. Johansen C.T., Wang J., Lanktree M.B., Cao H., McIntyre A.D., Ban M.R., Martins R.A., Kennedy B.A., Hassell R.G., Visser M.E., Schwartz S.M., Voight B.F., Elosua R., Salomaa V., O'Donnell C.J., Dallinga-Thie G.M., Anand S.S., Yusuf S., Huff M.W., Kathiresan S., Hegele R.A. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat. Genet. 2010, 42:684-687.
82. Jones A., Friedrich K., Rohm M., Schafer M., Algire C., Kulozik P., Seibert O., Muller-Decker K., Sijmonsma T., Strzoda D., Sticht C., Gretz N., Dallinga-Thie G.M., Leuchs B., Kogl M., Stremmel W., Diaz M.B., Herzig S. TSC22D4 is a molecular output of hepatic wasting metabolism. EMBO Mol. Med. 2013, 5:294-308.
83. Jones B., Jones E.L., Bonney S.A., Patel H.N., Mensenkamp A.R., Eichenbaum-Voline S., Rudling M., Myrdal U., Annesi G., Naik S., Meadows N., Quattrone A., Islam S.A., Naoumova R.P., Angelin B., Infante R., Levy E., Roy C.C., Freemont P.S., Scott J., Shoulders C.C. Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders. Nat. Genet. 2003, 34:29-31.
84. Jones C., Hammer R.E., Li W.P., Cohen J.C., Hobbs H.H., Herz J. Normal sorting but defective endocytosis of the low density lipoprotein receptor in mice with autosomal recessive hypercholesterolemia. J. Biol. Chem. 2003, 278:29024-29030.
85. Joyce C., Freeman L., Brewer H.B., Santamarina-Fojo S. Study of ABCA1 function in transgenic mice. Arterioscler. Thromb. Vasc. Biol. 2003, 23:965-971.
86. Kadlecova M., Hojna S., Bohuslavova R., Hubacek J.A., Zicha J., Kunes J. Apolipoprotein A5 and hypertriglyceridemia in Prague hypertriglyceridemic rats. Physiol. Res. 2006, 55:373-379.
87. Kadowaki T., Kadowaki H., Accili D., Taylor S.I. Substitution of lysine for asparagine at position 15 in the alpha-subunit of the human insulin receptor. A mutation that impairs transport of receptors to the cell surface and decreases the affinity of insulin binding. J. Biol. Chem. 1990, 265:19143-19150.
88. Kathiresan S., Melander O., Guiducci C., Surti A., Burtt N.P., Rieder M.J., Cooper G.M., Roos C., Voight B.F., Havulinna A.S., Wahlstrand B., Hedner T., Corella D., Tai E.S., Ordovas J.M., Berglund G., Vartiainen E., Jousilahti P., Hedblad B., Taskinen M.R., Newton-Cheh C., Salomaa V., Peltonen L., Groop L., Altshuler D.M., Orho-Melander M. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 2008, 40:189-197.
89. Kennedy M.A., Barrera G.C., Nakamura K., Baldan A., Tarr P., Fishbein M.C., Frank J., Francone O.L., Edwards P.A. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab. 2005, 1:121-131.
90. Khetarpal S.A., Edmondson A.C., Raghavan A., Neeli H., Jin W., Badellino K.O., Demissie S., Manning A.K., DerOhannessian S.L., Wolfe M.L., Cupples L.A., Li M., Kathiresan S., Rader D.J. Mining the LIPG allelic spectrum reveals the contribution of rare and common regulatory variants to HDL cholesterol. PLoS Genet. 2011, 7:e1002393.
91. Kim C.A., Delepine M., Boutet E., El Mourabit H., Le Lay S., Meier M., Nemani M., Bridel E., Leite C.C., Bertola D.R., Semple R.K., O'Rahilly S., Dugail I., Capeau J., Lathrop M., Magre J. Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J. Clin. Endocrinol. Metab. 2008, 93:1129-1134.
92. Kim H.J., Kobayashi M., Sasaki T., Kikuchi O., Amano K., Kitazumi T., Lee Y.S., Yokota-Hashimoto H., Susanti V.Y., Kitamura Y.I., Nakae J., Kitamura T. Overexpression of FoxO1 in the hypothalamus and pancreas causes obesity and glucose intolerance. Endocrinology 2012, 153:659-671.
93. Kjolby M., Andersen O.M., Breiderhoff T., Fjorback A.W., Pedersen K.M., Madsen P., Jansen P., Heeren J., Willnow T.E., Nykjaer A. Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab. 2010, 12:213-223.
94. Kobayashi T., Ito T., Shiomi M. Roles of the WHHL rabbit in translational research on hypercholesterolemia and cardiovascular diseases. J. Biomed. Biotechnol. 2011, 2011:406473.
95. Koishi R., Ando Y., Ono M., Shimamura M., Yasumo H., Fujiwara T., Horikoshi H., Furukawa H. Angptl3 regulates lipid metabolism in mice. Nat. Genet. 2002, 30:151-157.
96. Koster A., Chao Y.B., Mosior M., Ford A., Gonzalez-DeWhitt P.A., Hale J.E., Li D., Qiu Y., Fraser C.C., Yang D.D., Heuer J.G., Jaskunas S.R., Eacho P. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology 2005, 146:4943-4950.
97. Kurahashi T., Konno T., Otsuki N., Kwon M., Tsunoda S., Ito J., Fujii J. A malfunction in triglyceride transfer from the intracellular lipid pool to apoB in enterocytes of SOD1-deficient mice. FEBS Lett. 2012, 586:4289-4295.
98. Lage K., Karlberg E.O., Storling Z.M., Olason P.I., Pedersen A.G., Rigina O., Hinsby A.M., Tumer Z., Pociot F., Tommerup N., Moreau Y., Brunak S. A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat. Biotechnol. 2007, 25:309-316.
99. Lange L.A., Hu Y., Zhang H., Xue C., Schmidt E.M., Tang Z.Z., Bizon C., Lange E.M., Smith J.D., Turner E.H., Jun G., Kang H.M., Peloso G., Auer P., Li K.P., Flannick J., Zhang J., Fuchsberger C., Gaulton K., Lindgren C., Locke A., Manning A., Sim X., Rivas M.A., Holmen O.L., Gottesman O., Lu Y., Ruderfer D., Stahl E.A., Duan Q., Li Y., Durda P., Jiao S., Isaacs A., Hofman A., Bis J.C., Correa A., Griswold M.E., Jakobsdottir J., Smith A.V., Schreiner P.J., Feitosa M.F., Zhang Q., Huffman J.E., Crosby J., Wassel C.L., Do R., Franceschini N., Martin L.W., Robinson J.G., Assimes T.L., Crosslin D.R., Rosenthal E.A., Tsai M., Rieder M.J., Farlow D.N., Folsom A.R., Lumley T., Fox E.R., Carlson C.S., Peters U., Jackson R.D., van Duijn C.M., Uitterlinden A.G., Levy D., Rotter J.I., Taylor H.A., Gudnason V., Siscovick D.S., Fornage M., Borecki I.B., Hayward C., Rudan I., Chen Y.E., Bottinger E.P., Loos R.J., Saetrom P., Hveem K., Boehnke M., Groop L., McCarthy M., Meitinger T., Ballantyne C.M., Gabriel S.B., O'Donnell C.J., Post W.S., North K.E., Reiner A.P., Boerwinkle E., Psaty B.M., Altshuler D., Kathiresan S., Lin D.Y., Jarvik G.P., Cupples L.A., Kooperberg C., Wilson J.G., Nickerson D.A., Abecasis G.R., Rich S.S., Tracy R.P., Willer C.J. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am. J. Hum. Genet. 2014, 94:233-245.
100. Larrosa-Haro A., Melgoza-Radillo M., Sanchez-Ramirez C.A., Hurtado-Lopez E.F. Serum lipids in parents and siblings of children with Alagille syndrome: a pilot study. Hepatogastroenterology 2008, 55:1-3.
101. Lee A.H., Scapa E.F., Cohen D.E., Glimcher L.H. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 2008, 320:1492-1496.
102. Lee C.Y., Krimbou L., Vincent J., Bernard C., Larramee P., Genest J., Marcil M. Compound heterozygosity at the sphingomyelin phosphodiesterase-1 (SMPD1) gene is associated with low HDL cholesterol. Hum. Genet. 2003, 112:552-562.
103. Lee J.H., Giannikopoulos P., Duncan S.A., Wang J., Johansen C.T., Brown J.D., Plutzky J., Hegele R.A., Glimcher L.H., Lee A.H. The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism. Nat. Med. 2011, 17:812-815.
104. Lee M.H., Lu K., Hazard S., Yu H., Shulenin S., Hidaka H., Kojima H., Allikmets R., Sakuma N., Pegoraro R., Srivastava A.K., Salen G., Dean M., Patel S.B. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat. Genet. 2001, 27:79-83.
105. Lehrman M.A., Goldstein J.L., Brown M.S., Russell D.W., Schneider W.J. Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain. Cell 1985, 41:735-743.
106. Lei K.J., Shelly L.L., Pan C.J., Sidbury J.B., Chou J.Y. Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science 1993, 262:580-583.
107. Levy E., Brunet S., Alvarez F., Seidman E., Bouchard G., Escobar E., Martin S. Abnormal hepatobiliary and circulating lipid metabolism in the Long-Evans Cinnamon rat model of Wilson's disease. Life Sci. 2007, 80:1472-1483.
108. Linsel-Nitschke P., Heeren J., Aherrahrou Z., Bruse P., Gieger C., Illig T., Prokisch H., Heim K., Doering A., Peters A., Meitinger T., Wichmann H.E., Hinney A., Reinehr T., Roth C., Ortlepp J.R., Soufi M., Sattler A.M., Schaefer J., Stark K., Hengstenberg C., Schaefer A., Schreiber S., Kronenberg F., Samani N.J., Schunkert H., Erdmann J. Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis 2010, 208:183-189.
109. Linton M.F., Farese R.V., Chiesa G., Grass D.S., Chin P., Hammer R.E., Hobbs H.H., Young S.G. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J. Clin. Invest. 1993, 92:3029-3037.
110. Liou H.C., Boothby M.R., Finn P.W., Davidon R., Nabavi N., Zeleznik-Le N.J., Ting J.P., Glimcher L.H. A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter. Science 1990, 247:1581-1584.
111. Lundasen T., Andersson E.M., Snaith M., Lindmark H., Lundberg J., Ostlund-Lindqvist A.M., Angelin B., Rudling M. Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice. PLoS ONE 2012, 7:e37787.
112. Lusis A.J., Heinzmann C., Sparkes R.S., Scott J., Knott T.J., Geller R., Sparkes M.C., Mohandas T. Regional mapping of human chromosome 19: organization of genes for plasma lipid transport (APOC1, -C2, and -E and LDLR) and the genes C3, PEPD, and GPI. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:3929-3933.
113. Ma T., Jayaraman S., Wang K.S., Song Y., Yang B., Li J., Bastidas J.A., Verkman A.S. Defective dietary fat processing in transgenic mice lacking aquaporin-1 water channels. Am. J. Physiol. Cell Physiol. 2001, 280:C126-C134.
114. Maeda N., Li H., Lee D., Oliver P., Quarfordt S.H., Osada J. Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J. Biol. Chem. 1994, 269:23610-23616.
115. Magre J., Delepine M., Khallouf E., Gedde-Dahl T., Van Maldergem L., Sobel E., Papp J., Meier M., Megarbane A., Bachy A., Verloes A., d'Abronzo F.H., Seemanova E., Assan R., Baudic N., Bourut C., Czernichow P., Huet F., Grigorescu F., de K.M., Lacombe D., Labrune P., Lanza M., Loret H., Matsuda F., Navarro J., Nivelon-Chevalier A., Polak M., Robert J.J., Tric P., Tubiana-Rufi N., Vigouroux C., Weissenbach J., Savasta S., Maassen J.A., Trygstad O., Bogalho P., Freitas P., Medina J.L., Bonnicci F., Joffe B.I., Loyson G., Panz V.R., Raal F.J., O'Rahilly S., Stephenson T., Kahn C.R., Lathrop M., Capeau J. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat. Genet. 2001, 28:365-370.
116. Mamontova A., Seguret-Mace S., Esposito B., Chaniale C., Bouly M., Delhaye-Bouchaud N., Luc G., Staels B., Duverger N., Mariani J., Tedgui A. Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha. Circulation 1998, 98:2738-2743.
117. Marcais C., Verges B., Charriere S., Pruneta V., Merlin M., Billon S., Perrot L., Drai J., Sassolas A., Pennacchio L.A., Fruchart-Najib J., Fruchart J.C., Durlach V., Moulin P. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J. Clin. Invest. 2005, 115:2862-2869.
118. Marduel M., Ouguerram K., Serre V., Bonnefont-Rousselot D., Marques-Pinheiro A., Erik B.K., Devillers M., Luc G., Lecerf J.M., Tosolini L., Erlich D., Peloso G.M., Stitziel N., Nitchke P., Jais J.P., Abifadel M., Kathiresan S., Leren T.P., Rabes J.P., Boileau C., Varret M. Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation. Hum. Mutat. 2013, 34:83-87.
119. Marzal-Casacuberta A., Blanco-Vaca F., Ishida B.Y., Julve-Gil J., Shen J., Calvet-Marquez S., Gonzalez-Sastre F., Chan L. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II. J. Biol. Chem. 1996, 271:6720-6728.
120. Matsushima Y., Hayashi S., Tachibana M. Spontaneously hyperlipidemic (SHL) mice: Japanese wild mice with apolipoprotein E deficiency. Mamm. Genome 1999, 10:352-357.
121. Matsushima Y., Sakurai T., Ohoka A., Ohnuki T., Tada N., Asoh Y., Tachibana M. Four strains of spontaneously hyperlipidemic (SHL) mice: phenotypic distinctions determined by genetic backgrounds. J. Atheroscler. Thromb. 2001, 8:71-79.
122. Mezdour H., Larigauderie G., Castro G., Torpier G., Fruchart J., Nowak M., Fruchart J.C., Rouis M., Maeda N. Characterization of a new mouse model for human apolipoprotein A-I/C-III/A-IV deficiency. J. Lipid Res. 2006, 47:912-920.
123. Montague C.T., Farooqi I.S., Whitehead J.P., Soos M.A., Rau H., Wareham N.J., Sewter C.P., Digby J.E., Mohammed S.N., Hurst J.A., Cheetham C.H., Earley A.R., Barnett A.H., Prins J.B., O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997, 387:903-908.
124. Moon Y.A., Liang G., Xie X., Frank-Kamenetsky M., Fitzgerald K., Koteliansky V., Brown M.S., Goldstein J.L., Horton J.D. The Scap/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals. Cell Metab. 2012, 15:240-246.
125. Moore R.E., Kawashiri M.A., Kitajima K., Secreto A., Millar J.S., Pratico D., Rader D.J. Apolipoprotein A-I deficiency results in markedly increased atherosclerosis in mice lacking the LDL receptor. Arterioscler. Thromb. Vasc. Biol. 2003, 23:1914-1920.
126. Morrison A.C., Voorman A., Johnson A.D., Liu X., Yu J., Li A., Muzny D., Yu F., Rice K., Zhu C., Bis J., Heiss G., O'Donnell C.J., Psaty B.M., Cupples L.A., Gibbs R., Boerwinkle E. Whole-genome sequence-based analysis of high-density lipoprotein cholesterol. Nat. Genet. 2013, 45:899-901.
127. Motazacker M.M., Peter J., Treskes M., Shoulders C.C., Kuivenhoven J.A., Hovingh G.K. Evidence of a polygenic origin of extreme high-density lipoprotein cholesterol levels. Arterioscler. Thromb. Vasc. Biol. 2013, 33:1521-1528.
128. Motazacker M.M., Pirruccello J., Huijgen R., Do R., Gabriel S., Peter J., Kuivenhoven J.A., Defesche J.C., Kastelein J.J., Hovingh G.K., Zelcer N., Kathiresan S., Fouchier S.W. Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia. Eur. Heart J. 2012, 33:1360-1366.
129. Murayama T., Yokode M., Horiuchi H., Yoshida H., Sano H., Kita T. Overexpression of low density lipoprotein receptor eliminates apolipoprotein B100-containing lipoproteins from circulation and markedly prevents early atherogenesis in apolipoprotein E-deficient mice. Atherosclerosis 2000, 153:295-302.
130. Musunuru K., Pirruccello J.P., Do R., Peloso G.M., Guiducci C., Sougnez C., Garimella K.V., Fisher S., Abreu J., Barry A.J., Fennell T., Banks E., Ambrogio L., Cibulskis K., Kernytsky A., Gonzalez E., Rudzicz N., Engert J.C., DePristo M.A., Daly M.J., Cohen J.C., Hobbs H.H., Altshuler D., Schonfeld G., Gabriel S.B., Yue P., Kathiresan S. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. N. Engl. J. Med. 2010, 363:2220-2227.
131. Musunuru K., Strong A., Frank-Kamenetsky M., Lee N.E., Ahfeldt T., Sachs K.V., Li X., Li H., Kuperwasser N., Ruda V.M., Pirruccello J.P., Muchmore B., Prokunina-Olsson L., Hall J.L., Schadt E.E., Morales C.R., Lund-Katz S., Phillips M.C., Wong J., Cantley W., Racie T., Ejebe K.G., Orho-Melander M., Melander O., Koteliansky V., Fitzgerald K., Krauss R.M., Cowan C.A., Kathiresan S., Rader D.J. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010, 466:714-719.
132. Nagashima S., Yagyu H., Ohashi K., Tazoe F., Takahashi M., Ohshiro T., Bayasgalan T., Okada K., Sekiya M., Osuga J., Ishibashi S. Liver-specific deletion of 3-hydroxy-3-methylglutaryl coenzyme A reductase causes hepatic steatosis and death. Arterioscler. Thromb. Vasc. Biol. 2012, 32:1824-1831.
133. Nakata S., Tsutsui M., Shimokawa H., Suda O., Morishita T., Shibata K., Yatera Y., Sabanai K., Tanimoto A., Nagasaki M., Tasaki H., Sasaguri Y., Nakashima Y., Otsuji Y., Yanagihara N. Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms. Circulation 2008, 117:2211-2223.
134. Ng D.S., Francone O.L., Forte T.M., Zhang J., Haghpassand M., Rubin E.M. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I. J. Biol. Chem. 1997, 272:15777-15781.
135. Noga A.A., Vance D.E. Insights into the requirement of phosphatidylcholine synthesis for liver function in mice. J. Lipid Res. 2003, 44:1998-2005.
136. Nowaczyk M.J., Irons M.B. Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology. Am. J. Med. Genet. C: Semin. Med. Genet. 2012, 160C:250-262.
137. Odawara M., Kadowaki T., Yamamoto R., Shibasaki Y., Tobe K., Accili D., Bevins C., Mikami Y., Matsuura N., Akanuma Y. Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor. Science 1989, 245:66-68.
138. Oelkers P., Kirby L.C., Heubi J.E., Dawson P.A. Primary bile acid malabsorption caused by mutations in the ileal sodium-dependent bile acid transporter gene (SLC10A2). J. Clin. Invest. 1997, 99:1880-1887.
139. Orso E., Broccardo C., Kaminski W.E., Bottcher A., Liebisch G., Drobnik W., Gotz A., Chambenoit O., Diederich W., Langmann T., Spruss T., Luciani M.F., Rothe G., Lackner K.J., Chimini G., Schmitz G. Transport of lipids from golgi to plasma membrane is defective in Tangier disease patients and Abc1-deficient mice. Nat. Genet. 2000, 24:192-196.
140. Osuga J., Ishibashi S., Oka T., Yagyu H., Tozawa R., Fujimoto A., Shionoiri F., Yahagi N., Kraemer F.B., Tsutsumi O., Yamada N. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:787-792.
141. Paigen B., Albee D., Holmes P.A., Mitchell D. Genetic analysis of murine strains C57BL/6J and C3H/HeJ to confirm the map position of Ath-1, a gene determining atherosclerosis susceptibility. Biochem. Genet. 1987, 25:501-511.
142. Paigen B., Mitchell D., Reue K., Morrow A., Lusis A.J., LeBoeuf R.C. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:3763-3767.
143. Park S.W., Moon Y.A., Horton J.D. Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver. J. Biol. Chem. 2004, 279:50630-50638.
144. Paterniti J.R., Brown W.V., Ginsberg H.N., Artzt K. Combined lipase deficiency (cld): a lethal mutation on chromosome 17 of the mouse. Science 1983, 221:167-169.
145. Peloso G.M., Auer P.L., Bis J.C., Voorman A., Morrison A.C., Stitziel N.O., Brody J.A., Khetarpal S.A., Crosby J.R., Fornage M., Isaacs A., Jakobsdottir J., Feitosa M.F., Davies G., Huffman J.E., Manichaikul A., Davis B., Lohman K., Joon A.Y., Smith A.V., Grove M.L., Zanoni P., Redon V., Demissie S., Lawson K., Peters U., Carlson C., Jackson R.D., Ryckman K.K., Mackey R.H., Robinson J.G., Siscovick D.S., Schreiner P.J., Mychaleckyj J.C., Pankow J.S., Hofman A., Uitterlinden A.G., Harris T.B., Taylor K.D., Stafford J.M., Reynolds L.M., Marioni R.E., Dehghan A., Franco O.H., Patel A.P., Lu Y., Hindy G., Gottesman O., Bottinger E.P., Melander O., Orho-Melander M., Loos R.J., Duga S., Merlini P.A., Farrall M., Goel A., Asselta R., Girelli D., Martinelli N., Shah S.H., Kraus W.E., Li M., Rader D.J., Reilly M.P., McPherson R., Watkins H., Ardissino D., Zhang Q., Wang J., Tsai M.Y., Taylor H.A., Correa A., Griswold M.E., Lange L.A., Starr J.M., Rudan I., Eiriksdottir G., Launer L.J., Ordovas J.M., Levy D., Chen Y.D., Reiner A.P., Hayward C., Polasek O., Deary I.J., Borecki I.B., Liu Y., Gudnason V., Wilson J.G., van Duijn C.M., Kooperberg C., Rich S.S., Psaty B.M., Rotter J.I., O'Donnell C.J., Rice K., Boerwinkle E., Kathiresan S., Cupples L.A. Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am. J. Hum. Genet. 2014, 94:223-232.
146. Peng X. Transgenic rabbit models for studying human cardiovascular diseases. Comp. Med. 2012, 62:472-479.
147. Pennacchio L.A., Olivier M., Hubacek J.A., Cohen J.C., Cox D.R., Fruchart J.C., Krauss R.M., Rubin E.M. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001, 294:169-173.
148. Peritz L.N., Brunzell J.D., Harvey-Clarke C., Pritchard P.H., Jones B.R., Hayden M.R. Characterization of a lipoprotein lipase class III type defect in hypertriglyceridemic cats. Clin. Invest. Med. 1990, 13:259-263.
149. Peterfy M., Ben-Zeev O., Mao H.Z., Weissglas-Volkov D., Aouizerat B.E., Pullinger C.R., Frost P.H., Kane J.P., Malloy M.J., Reue K., Pajukanta P., Doolittle M.H. Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. Nat. Genet. 2007, 39:1483-1487.
150. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M., Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71:343-353.
151. Pollin T.I., Damcott C.M., Shen H., Ott S.H., Shelton J., Horenstein R.B., Post W., McLenithan J.C., Bielak L.F., Peyser P.A., Mitchell B.D., Miller M., O'Connell J.R., Shuldiner A.R. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 2008, 322:1702-1705.
152. Pulawa L.K., Jensen D.R., Coates A., Eckel R.H. Reduction of plasma triglycerides in apolipoprotein C-II transgenic mice overexpressing lipoprotein lipase in muscle. J. Lipid Res. 2007, 48:145-151.
153. Quazi F., Molday R.S. Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants. J. Biol. Chem. 2013, 288:34414-34426.
154. Raabe M., Flynn L.M., Zlot C.H., Wong J.S., Veniant M.M., Hamilton R.L., Young S.G. Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:8686-8691.
155. Rashid S., Curtis D.E., Garuti R., Anderson N.N., Bashmakov Y., Ho Y.K., Hammer R.E., Moon Y.A., Horton J.D. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:5374-5379.
156. Rigotti A., Trigatti B.L., Penman M., Rayburn H., Herz J., Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:12610-12615.
157. Rios J., Stein E., Shendure J., Hobbs H.H., Cohen J.C. Identification by whole-genome resequencing of gene defect responsible for severe hypercholesterolemia. Hum. Mol. Genet. 2010, 19:4313-4318.
158. Rios J.J., Shastry S., Jasso J., Hauser N., Garg A., Bensadoun A., Cohen J.C., Hobbs H.H. Deletion of GPIHBP1 causing severe chylomicronemia. J. Inherit. Metab. Dis. 2012, 35:531-540.
159. Romeo S., Pennacchio L.A., Fu Y., Boerwinkle E., Tybjaerg-Hansen A., Hobbs H.H., Cohen J.C. Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL. Nat. Genet. 2007, 39:513-516.
160. Romeo S., Yin W., Kozlitina J., Pennacchio L.A., Boerwinkle E., Hobbs H.H., Cohen J.C. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. J. Clin. Invest. 2009, 119:70-79.
161. Rosenthal E.A., Ranchalis J., Crosslin D.R., Burt A., Brunzell J.D., Motulsky A.G., Nickerson D.A., Wijsman E.M., Jarvik G.P. Joint linkage and association analysis with exome sequence data implicates SLC25A40 in hypertriglyceridemia. Am. J. Hum. Genet. 2013, 93:1035-1045.
162. Rubin E.M., Krauss R.M., Spangler E.A., Verstuyft J.G., Clift S.M. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 1991, 353:265-267.
163. Rubio-Cabezas O., Puri V., Murano I., Saudek V., Semple R.K., Dash S., Hyden C.S., Bottomley W., Vigouroux C., Magre J., Raymond-Barker P., Murgatroyd P.R., Chawla A., Skepper J.N., Chatterjee V.K., Suliman S., Patch A.M., Agarwal A.K., Garg A., Barroso I., Cinti S., Czech M.P., Argente J., O'Rahilly S., Savage D.B. Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol. Med. 2009, 1:280-287.
164. Runz H. Integrated approaches to functionally characterize novel factors in lipoprotein metabolism. Curr. Opin. Lipidol. 2012, 23:104-110.
165. Russell J.C., Graham S.E., Amy R.M., Dolphin P.J. Cardioprotective effect of probucol in the atherosclerosis-prone JCR:LA-cp rat. Eur. J. Pharmacol. 1998, 350:203-210.
166. Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J.C., Deleuze J.F., Brewer H.B., Duverger N., Denefle P., Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 1999, 22:352-355.
167. Schou J., Frikke-Schmidt R., Kardassis D., Thymiakou E., Nordestgaard B.G., Jensen G., Grande P., Tybjaerg-Hansen A. Genetic variation in ABCG1 and risk of myocardial infarction and ischemic heart disease. Arterioscler. Thromb. Vasc. Biol. 2012, 32:506-515.
168. Semple R.K., Sleigh A., Murgatroyd P.R., Adams C.A., Bluck L., Jackson S., Vottero A., Kanabar D., Charlton-Menys V., Durrington P., Soos M.A., Carpenter T.A., Lomas D.J., Cochran E.K., Gorden P., O'Rahilly S., Savage D.B. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J. Clin. Invest. 2009, 119:315-322.
169. Shachter N.S., Ebara T., Ramakrishnan R., Steiner G., Breslow J.L., Ginsberg H.N., Smith J.D. Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl. J. Clin. Invest. 1996, 98:846-855.
170. Sharp D., Blinderman L., Combs K.A., Kienzle B., Ricci B., Wager-Smith K., Gil C.M., Turck C.W., Bouma M.E., Rader D.J. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature 1993, 365:65-69.
171. Shih D.Q., Navas M.A., Kuwajima S., Duncan S.A., Stoffel M. Impaired glucose homeostasis and neonatal mortality in hepatocyte nuclear factor 3alpha-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:10152-10157.
172. Shimada M., Shimano H., Gotoda T., Yamamoto K., Kawamura M., Inaba T., Yazaki Y., Yamada N. Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia. J. Biol. Chem. 1993, 268:17924-17929.
173. Shimizugawa T., Ono M., Shimamura M., Yoshida K., Ando Y., Koishi R., Ueda K., Inaba T., Minekura H., Kohama T., Furukawa H. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J. Biol. Chem. 2002, 277:33742-33748.
174. Shimoda T., Ishihata A., Aita T., Kaga M., Ito T., Ohwada K., Tomoike H., Katano Y. Progression of severe atherosclerosis and increased arterial pulse pressure in the newly developed heritable mixed hyperlipidaemic rabbits. Clin. Exp. Pharmacol. Physiol. 2006, 33:221-226.
175. Shinohara M., Masuyama T., Shoda T., Takahashi T., Katsuda Y., Komeda K., Kuroki M., Kakehashi A., Kanazawa Y. A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications. Int. J. Exp. Diabetes Res. 2000, 1:89-100.
176. Singaraja R.R., Fievet C., Castro G., James E.R., Hennuyer N., Clee S.M., Bissada N., Choy J.C., Fruchart J.C., McManus B.M., Staels B., Hayden M.R. Increased ABCA1 activity protects against atherosclerosis. J. Clin. Invest. 2002, 110:35-42.
177. Singhal J., Nagaprashantha L., Vatsyayan R., Awasthi S., Singhal S.S. RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndrome. PLoS ONE 2011, 6:e24688.
178. Soria L.F., Ludwig E.H., Clarke H.R., Vega G.L., Grundy S.M., McCarthy B.J. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc. Natl. Acad. Sci. U. S. A. 1989, 86:587-591.
179. Sorrentino V., Fouchier S.W., Motazacker M.M., Nelson J.K., Defesche J.C., Dallinga-Thie G.M., Kastelein J.J., Kees H.G., Zelcer N. Identification of a loss-of-function inducible degrader of the low-density lipoprotein receptor variant in individuals with low circulating low-density lipoprotein. Eur. Heart J. 2013, 34:1292-1297.
180. Stitziel N.O., Fouchier S.W., Sjouke B., Peloso G.M., Moscoso A.M., Auer P.L., Goel A., Gigante B., Barnes T.A., Melander O., Orho-Melander M., Duga S., Sivapalaratnam S., Nikpay M., Martinelli N., Girelli D., Jackson R.D., Kooperberg C., Lange L.A., Ardissino D., McPherson R., Farrall M., Watkins H., Reilly M.P., Rader D.J., de Faire U., Schunkert H., Erdmann J., Samani N.J., Charnas L., Altshuler D., Gabriel S., Kastelein J.J., Defesche J.C., Nederveen A.J., Kathiresan S., Hovingh G.K. Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 2013, 33:2909-2914.
181. Stoffers D.A., Ferrer J., Clarke W.L., Habener J.F. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat. Genet. 1997, 17:138-139.
182. Talmud P.J., Shah S., Whittall R., Futema M., Howard P., Cooper J.A., Harrison S.C., Li K., Drenos F., Karpe F., Neil H.A., Descamps O.S., Langenberg C., Lench N., Kivimaki M., Whittaker J., Hingorani A.D., Kumari M., Humphries S.E. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study. Lancet 2013, 381:1293-1301.
183. Taschler U., Radner F.P., Heier C., Schreiber R., Schweiger M., Schoiswohl G., Preiss-Landl K., Jaeger D., Reiter B., Koefeler H.C., Wojciechowski J., Theussl C., Penninger J.M., Lass A., Haemmerle G., Zechner R., Zimmermann R. Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. J. Biol. Chem. 2011, 286:17467-17477.
184. Teslovich T.M., Musunuru K., Smith A.V., Edmondson A.C., Stylianou I.M., Koseki M., Pirruccello J.P., Ripatti S., Chasman D.I., Willer C.J., Johansen C.T., Fouchier S.W., Isaacs A., Peloso G.M., Barbalic M., Ricketts S.L., Bis J.C., Aulchenko Y.S., Thorleifsson G., Feitosa M.F., Chambers J., Orho-Melander M., Melander O., Johnson T., Li X., Guo X., Li M., Shin C.Y., Jin G.M., Jin K.Y., Lee J.Y., Park T., Kim K., Sim X., Twee-Hee O.R., Croteau-Chonka D.C., Lange L.A., Smith J.D., Song K., Hua Z.J., Yuan X., Luan J., Lamina C., Ziegler A., Zhang W., Zee R.Y., Wright A.F., Witteman J.C., Wilson J.F., Willemsen G., Wichmann H.E., Whitfield J.B., Waterworth D.M., Wareham N.J., Waeber G., Vollenweider P., Voight B.F., Vitart V., Uitterlinden A.G., Uda M., Tuomilehto J., Thompson J.R., Tanaka T., Surakka I., Stringham H.M., Spector T.D., Soranzo N., Smit J.H., Sinisalo J., Silander K., Sijbrands E.J., Scuteri A., Scott J., Schlessinger D., Sanna S., Salomaa V., Saharinen J., Sabatti C., Ruokonen A., Rudan I., Rose L.M., Roberts R., Rieder M., Psaty B.M., Pramstaller P.P., Pichler I., Perola M., Penninx B.W., Pedersen N.L., Pattaro C., Parker A.N., Pare G., Oostra B.A., O'Donnell C.J., Nieminen M.S., Nickerson D.A., Montgomery G.W., Meitinger T., McPherson R., McCarthy M.I., McArdle W., Masson D., Martin N.G., Marroni F., Mangino M., Magnusson P.K., Lucas G., Luben R., Loos R.J., Lokki M.L., Lettre G., Langenberg C., Launer L.J., Lakatta E.G., Laaksonen R., Kyvik K.O., Kronenberg F., Konig I.R., Khaw K.T., Kaprio J., Kaplan L.M., Johansson A., Jarvelin M.R., Janssens A.C., Ingelsson E., Igl W., Kees H.G., Hottenga J.J., Hofman A., Hicks A.A., Hengstenberg C., Heid I.M., Hayward C., Havulinna A.S., Hastie N.D., Harris T.B., Haritunians T., Hall A.S., Gyllensten U., Guiducci C., Groop L.C., Gonzalez E., Gieger C., Freimer N.B., Ferrucci L., Erdmann J., Elliott P., Ejebe K.G., Doring A., Dominiczak A.F., Demissie S., Deloukas P., de Geus E.J., de Faire U., Crawford G., Collins F.S., Chen Y.D., Caulfield M.J., Campbell H., Burtt N.P., Bonnycastle L.L., Boomsma D.I., Boekholdt S.M., Bergman R.N., Barroso I., Bandinelli S., Ballantyne C.M., Assimes T.L., Quertermous T., Altshuler D., Seielstad M., Wong T.Y., Tai E.S., Feranil A.B., Kuzawa C.W., Adair L.S., Taylor H.A., Borecki I.B., Gabriel S.B., Wilson J.G., Holm H., Thorsteinsdottir U., Gudnason V., Krauss R.M., Mohlke K.L., Ordovas J.M., Munroe P.B., Kooner J.S., Tall A.R., Hegele R.A., Kastelein J.J., Schadt E.E., Rotter J.I., Boerwinkle E., Strachan D.P., Mooser V., Stefansson K., Reilly M.P., Samani N.J., Schunkert H., Cupples L.A., Sandhu M.S., Ridker P.M., Rader D.J., van Duijn C.M., Peltonen L., Abecasis G.R., Boehnke M., Kathiresan S. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713.
185. Tollefson J.H., Ravnik S., Albers J.J. Isolation and characterization of a phospholipid transfer protein (LTP-II) from human plasma. J. Lipid Res. 1988, 29:1593-1602.
186. Ueda Y., Royer L., Gong E., Zhang J., Cooper P.N., Francone O., Rubin E.M. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J. Biol. Chem. 1999, 274:7165-7171.
187. Ueta C.B., Fernandes G.W., Capelo L.P., Fonseca T.L., Maculan F.D., Gouveia C.H., Brum P.C., Christoffolete M.A., Aoki M.S., Lancellotti C.L., Kim B., Bianco A.C., Ribeiro M.O. beta(1) Adrenergic receptor is key to cold- and diet-induced thermogenesis in mice. J. Endocrinol. 2012, 214:359-365.
188. Utech M., Hobbel G., Rust S., Reinecke H., Assmann G., Walter M. Accumulation of RhoA, RhoB, RhoG, and Rac1 in fibroblasts from Tangier disease subjects suggests a regulatory role of Rho family proteins in cholesterol efflux. Biochem. Biophys. Res. Commun. 2001, 280:229-236.
189. Vaisman B.L., Klein H.G., Rouis M., Berard A.M., Kindt M.R., Talley G.D., Meyn S.M., Hoyt R.F., Marcovina S.M., Albers J.J. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J. Biol. Chem. 1995, 270:12269-12275.
190. van den Maagdenberg A.M., Hofker M.H., Krimpenfort P.J., de Bruijn I., van Vlijmen B., van der Boom H., Havekes L.M., Frants R.R. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J. Biol. Chem. 1993, 268:10540-10545.
191. van Ree J.H., Hofker M.H., van den Broek W.J., van Deursen J.M., van der Boom H., Frants R.R., Wieringa B., Havekes L.M. Increased response to cholesterol feeding in apolipoprotein C1-deficient mice. Biochem. J. 1995, 305(Pt 3):905-911.
192. van Haperen R., van Tol A., van Gent T., Scheek L., Visser P., van der Kamp A., Grosveld F., de Crom R. Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein. J. Biol. Chem. 2002, 277:48938-48943.
193. Van Leuven F., Cassiman J.J., Van Den Berghe H. Demonstration of an alpha2-macroglobulin receptor in human fibroblasts, absent in tumor-derived cell lines. J. Biol. Chem. 1979, 254:5155-5160.
194. Vergeer M., Korporaal S.J., Franssen R., Meurs I., Out R., Hovingh G.K., Hoekstra M., Sierts J.A., Dallinga-Thie G.M., Motazacker M.M., Holleboom A.G., van Berkel T.J., Kastelein J.J., Van Eck M., Kuivenhoven J.A. Genetic variant of the scavenger receptor BI in humans. N. Engl. J. Med. 2011, 364:136-145.
195. von Eckardstein A., Funke H., Henke A., Altland K., Benninghoven A., Assmann G. Apolipoprotein A-I variants. Naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I. J. Clin. Invest. 1989, 84:1722-1730.
196. Vrins C.L., Out R., van Santbrink P., van der Zee A., Mahmoudi T., Groenendijk M., Havekes L.M., van Berkel T.J., Willems van Dijk K., Biessen E.A. Znf202 affects high density lipoprotein cholesterol levels and promotes hepatosteatosis in hyperlipidemic mice. PLoS ONE 2013, 8:e57492.
197. Wagner S., Hess M.A., Ormonde-Hanson P., Malandro J., Hu H., Chen M., Kehrer R., Frodsham M., Schumacher C., Beluch M., Honer C., Skolnick M., Ballinger D., Bowen B.R. A broad role for the zinc finger protein ZNF202 in human lipid metabolism. J. Biol. Chem. 2000, 275:15685-15690.
198. Walker A.P., Muscatelli F., Stafford A.N., Chelly J., Dahl N., Blomquist H.K., Delanghe J., Willems P.J., Steinmann B., Monaco A.P. Mutations and phenotype in isolated glycerol kinase deficiency. Am. J. Hum. Genet. 1996, 58:1205-1211.
199. Wang Q., Li S., Jiang L., Zhou Y., Li Z., Shao M., Li W., Liu Y. Deficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in mice. J. Lipid Res. 2010, 51:2516-2526.
200. Wang Y., Quagliarini F., Gusarova V., Gromada J., Valenzuela D.M., Cohen J.C., Hobbs H.H. Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasis. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:16109-16114.
201. Weinstock P.H., Bisgaier C.L., Aalto-Setala K., Radner H., Ramakrishnan R., Levak-Frank S., Essenburg A.D., Zechner R., Breslow J.L. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J. Clin. Invest. 1995, 96:2555-2568.
202. Weng W., Breslow J.L. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:14788-14794.
203. Westra H.J., Peters M.J., Esko T., Yaghootkar H., Schurmann C., Kettunen J., Christiansen M.W., Fairfax B.P., Schramm K., Powell J.E., Zhernakova A., Zhernakova D.V., Veldink J.H., Van den Berg L.H., Karjalainen J., Withoff S., Uitterlinden A.G., Hofman A., Rivadeneira F., 't Hoen P.A., Reinmaa E., Fischer K., Nelis M., Milani L., Melzer D., Ferrucci L., Singleton A.B., Hernandez D.G., Nalls M.A., Homuth G., Nauck M., Radke D., Volker U., Perola M., Salomaa V., Brody J., Suchy-Dicey A., Gharib S.A., Enquobahrie D.A., Lumley T., Montgomery G.W., Makino S., Prokisch H., Herder C., Roden M., Grallert H., Meitinger T., Strauch K., Li Y., Jansen R.C., Visscher P.M., Knight J.C., Psaty B.M., Ripatti S., Teumer A., Frayling T.M., Metspalu A., van Meurs J.B., Franke L. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 2013, 45:1238-1243.
204. Willer C.J., Schmidt E.M., Sengupta S., Peloso G.M., Gustafsson S., Kanoni S., Ganna A., Chen J., Buchkovich M.L., Mora S., Beckmann J.S., Bragg-Gresham J.L., Chang H.Y., Demirkan A., Den Hertog H.M., Do R., Donnelly L.A., Ehret G.B., Esko T., Feitosa M.F., Ferreira T., Fischer K., Fontanillas P., Fraser R.M., Freitag D.F., Gurdasani D., Heikkila K., Hypponen E., Isaacs A., Jackson A.U., Johansson A., Johnson T., Kaakinen M., Kettunen J., Kleber M.E., Li X., Luan J., Lyytikainen L.P., Magnusson P.K., Mangino M., Mihailov E., Montasser M.E., Muller-Nurasyid M., Nolte I.M., O'Connell J.R., Palmer C.D., Perola M., Petersen A.K., Sanna S., Saxena R., S.K.Service, Shah S., Shungin D., Sidore C., Song C., Strawbridge R.J., Surakka I., Tanaka T., Teslovich T.M., Thorleifsson G., Van den Herik E.G., Voight B.F., Volcik K.A., Waite L.L., Wong A., Wu Y., Zhang W., Absher D., Asiki G., Barroso I., Been L.F., Bolton J.L., Bonnycastle L.L., Brambilla P., Burnett M.S., Cesana G., Dimitriou M., Doney A.S., Doring A., Elliott P., Epstein S.E., Eyjolfsson G.I., Gigante B., Goodarzi M.O., Grallert H., Gravito M.L., Groves C.J., Hallmans G., Hartikainen A.L., Hayward C., Hernandez D., Hicks A.A., Holm H., Hung Y.J., Illig T., Jones M.R., Kaleebu P., Kastelein J.J., Khaw K.T., Kim E., Klopp N., Komulainen P., Kumari M., Langenberg C., Lehtimaki T., Lin S.Y., Lindstrom J., Loos R.J., Mach F., McArdle W.L., Meisinger C., Mitchell B.D., Muller G., Nagaraja R., Narisu N., Nieminen T.V., Nsubuga R.N., Olafsson I., Ong K.K., Palotie A., Papamarkou T., Pomilla C., Pouta A., Rader D.J., Reilly M.P., Ridker P.M., Rivadeneira F., Rudan I., Ruokonen A., Samani N., Scharnagl H., Seeley J., Silander K., Stancakova A., Stirrups K., Swift A.J., Tiret L., Uitterlinden A.G., van Pelt L.J., Vedantam S., Wainwright N., Wijmenga C., Wild S.H., Willemsen G., Wilsgaard T., Wilson J.F., Young E.H., Zhao J.H., Adair L.S., Arveiler D., Assimes T.L., Bandinelli S., Bennett F., Bochud M., Boehm B.O., Boomsma D.I., Borecki I.B., Bornstein S.R., Bovet P., Burnier M., Campbell H., Chakravarti A., Chambers J.C., Chen Y.D., Collins F.S., Cooper R.S., Danesh J., Dedoussis G., de Faire U., Feranil A.B., Ferrieres J., Ferrucci L., Freimer N.B., Gieger C., Groop L.C., Gudnason V., Gyllensten U., Hamsten A., Harris T.B., Hingorani A., Hirschhorn J.N., Hofman A., Hovingh G.K., Hsiung C.A., Humphries S.E., Hunt S.C., Hveem K., Iribarren C., Jarvelin M.R., Jula A., Kahonen M., Kaprio J., Kesaniemi A., Kivimaki M., Kooner J.S., Koudstaal P.J., Krauss R.M., Kuh D., Kuusisto J., Kyvik K.O., Laakso M., Lakka T.A., Lind L., Lindgren C.M., Martin N.G., Marz W., McCarthy M.I., McKenzie C.A., Meneton P., Metspalu A., Moilanen L., Morris A.D., Munroe P.B., Njolstad I., Pedersen N.L., Power C., Pramstaller P.P., Price J.F., Psaty B.M., Quertermous T., Rauramaa R., Saleheen D., Salomaa V., Sanghera D.K., Saramies J., Schwarz P.E., Sheu W.H., Shuldiner A.R., Siegbahn A., Spector T.D., Stefansson K., Strachan D.P., Tayo B.O., Tremoli E., Tuomilehto J., Uusitupa M., van Duijn C.M., Vollenweider P., Wallentin L., Wareham N.J., Whitfield J.B., Wolffenbuttel B.H., Ordovas J.M., Boerwinkle E., Palmer C.N., Thorsteinsdottir U., Chasman D.I., Rotter J.I., Franks P.W., Ripatti S., Cupples L.A., Sandhu M.S., Rich S.S., Boehnke M., Deloukas P. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 2013, 45:1274-1283.
205. Williamson R., Lee D., Hagaman J., Maeda N. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:7134-7138.
206. Wolfrum C., Poy M.N., Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat. Med. 2005, 11:418-422.
207. Wu J.E., Basso F., Shamburek R.D., Amar M.J., Vaisman B., Szakacs G., Joyce C., Tansey T., Freeman L., Paigen B.J., Thomas F., Brewer H.B., Santamarina-Fojo S. Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice. J. Biol. Chem. 2004, 279:22913-22925.
208. Xiong X., Tao R., DePinho R.A., Dong X.C. The autophagy-related gene 14 (Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and plays a critical role in hepatic autophagy and lipid metabolism. J. Biol. Chem. 2012, 287:39107-39114.
209. Xu N., Dahlback B. A novel human apolipoprotein (apoM). J. Biol. Chem. 1999, 274:31286-31290.
210. Yi P., Park J.S., Melton D.A. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell 2013, 153:747-758.
211. Young S.G., Bertics S.J., Curtiss L.K., Dubois B.W., Witztum J.L. Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100. J. Clin. Invest. 1987, 79:1842-1851.
212. Yu I.C., Lin H.Y., Liu N.C., Wang R.S., Sparks J.D., Yeh S., Chang C. Hyperleptinemia without obesity in male mice lacking androgen receptor in adipose tissue. Endocrinology 2008, 149:2361-2368.
213. Yu L., Hammer R.E., Li-Hawkins J., Von B.K., Lutjohann D., Cohen J.C., Hobbs H.H. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:16237-16242.
214. Zelcer N., Hong C., Boyadjian R., Tontonoz P. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 2009, 325:100-104.
215. Zhang C., Wang G., Zheng Z., Maddipati K.R., Zhang X., Dyson G., Williams P., Duncan S.A., Kaufman R.J., Zhang K. Endoplasmic reticulum-tethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice. Hepatology 2012, 55:1070-1082.
216. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992, 258:468-471.
217. Zhu J., Gardner J., Pullinger C.R., Kane J.P., Thompson J.F., Francone O.L. Regulation of apoAI processing by procollagen C-proteinase enhancer-2 and bone morphogenetic protein-1. J. Lipid Res. 2009, 50:1330-1339.
218. Zhu Y., Jong M.C., Frazer K.A., Gong E., Krauss R.M., Cheng J.F., Boffelli D., Rubin E.M. Genomic interval engineering of mice identifies a novel modulator of triglyceride production. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:1137-1142.